Volume 70, Pages S21-S25 (December 2006)

Slides:

Advertisements

Similar presentations

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Advertisements

A.M. Thompson, T.G. Pickering Kidney International

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations.

Anemia management in chronic kidney disease

Microalbuminuria, peripheral artery disease, and cognitive function

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Impact of new dialysis solutions on peritonitis rates

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Reassessment of the care of the patient with chronic kidney disease

Progression of renal failure and hypertensive nephrosclerosis

Inflammation and wasting in chronic kidney disease: Partners in crime

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Francesco Paolo Schena Kidney International

Need for better diabetes treatment for improved renal outcome

Volume 72, Issue 9, Pages (November 2007)

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

A new era in phosphate binder therapy: What are the options?

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

The epidemiology of chronic kidney disease

Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.

Prevention of renal failure: The Malaysian experience

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease S. Bianchi, R. Bigazzi, V.M. Campese

Volume 73, Pages S5-S17 (April 2008)

Volume 86, Issue 1, Pages (July 2014)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Blood pressure targets in hemodialysis patients

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

Recent experience with high-dose intravenous iron administration

Günter Weiss, Florian Kronenberg Kidney International

The third World Kidney Day: Looking back and thinking forward

Francesco Locatelli, Lucia Del Vecchio Kidney International

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Methods for guideline development

The global challenge of chronic kidney disease

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 73, Pages S72-S75 (April 2008)

Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell Kara K. Wools-Kaloustian, Samir K. Gupta Kidney.

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 72, Issue 2, Pages (July 2007)

Volume 55, Pages S3-S16 (June 1999)

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate S. Aime, C. Canavese, P. Stratta Kidney International

Volume 70, Issue 5, Pages (September 2006)

Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton

Volume 72, Issue 11, Pages (December 2007)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 69, Issue 8, Pages (April 2006)

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Volume 72, Issue 12, (December 2007)

Presentation transcript:

Volume 70, Pages S21-S25 (December 2006) The economic realities of erythropoiesis-stimulating agent therapy in kidney disease J.B. Wish Kidney International Volume 70, Pages S21-S25 (December 2006) DOI: 10.1038/sj.ki.5001972 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 EPO use in HD: 1989–1993.1 Kidney International 2006 70, S21-S25DOI: (10.1038/sj.ki.5001972) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Treatment of CKD patients with epoetin varies across the United States (2001–2002).9 Kidney International 2006 70, S21-S25DOI: (10.1038/sj.ki.5001972) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Prevalance of ESA Therapy by Stage of CKD. Kidney International 2006 70, S21-S25DOI: (10.1038/sj.ki.5001972) Copyright © 2006 International Society of Nephrology Terms and Conditions